QuestionSBA
QuestionChoice
Patients are more likely to experience chemotherapy-related nausea and vomiting in the first cycle of chemotherapy.
10035824
c
Undergoing a later cycle of a chemotherapy regimen
QuestionChoice
Younger patients are at a greater risk of chemotherapy-related nausea and vomiting.
10035822
a
Younger age
QuestionChoice
Whilst previously experiencing severe morning sickness is a risk factor for chemotherapy-related nausea and vomiting, history of pregnancy alone is not itself a risk factor.
10035826
e
History of pregnancy
QuestionChoice
Female patients are at higher risk of chemotherapy-related nausea and vomiting than male patients.
10035823
b
Male sex
QuestionChoice
This is incorrect, as these medications are used to treat chemotherapy-related nausea and vomiting.
10035825
d
Use of anti-emetic medications during chemotherapy
QuestionComment
risk factors - female, younger age
49751
QuestionComment
hx of morning sickness and first cycle of chemo
49752
User
subscriber
Kawasaki Lung
User
subscriber
Kawasaki Lung
Concept
Chapter
2693
6152
Differentials of nausea and vomiting and palliative care
Topic
225
Oncology and Palliative Care
19568
Younger patients undergoing chemotherapy have an increased risk of experiencing nausea and vomiting.
A 17-year-old female has recently been diagnosed with acute lymphoblastic leukaemia (ALL) after a 4-week history of extreme fatigue, easy bruising and lymphadenopathy. She is due to undergo induction chemotherapy for her ALL and is concerned about the possibility of nausea and vomiting. The patient would like to know if it is possible to avoid these symptoms and asks if anything increases the risk of nausea and vomiting related to chemotherapy.

Which of the following is a risk factor for chemotherapy-related nausea and vomiting?
a